Vertiv price target raised to $200 from $165 at Morgan Stanley

Morgan Stanley analyst Christopher Snyder raised the firm’s price target on Vertiv (VRT) to $200 from $165 and keeps an Overweight rating on the shares. Despite a 25% Q3 EPS beat and orders being up 60% year-over-year, shares traded down 2% with the market calling peak on the $3.7B order print and “some disappointment on mostly in line Q4 EPS guide,” the analyst tells investors. However, the firm takes “a far more constructive view” and exits Q3 results more positive on the 2026 outlook, the analyst added.